Literature DB >> 34842282

COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.

M Kasperkiewicz1, R Strong2, K Mead2, M Yale2, D Zillikens3, D T Woodley1, A Recke3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34842282     DOI： 10.1111/bjd.20906

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19.

Authors:  M Kasperkiewicz; D T Woodley
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-07       Impact factor: 9.228

Review 2.  Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.

Authors:  Xueyi Huang; Xiaoqian Liang; Jiao Zhang; Hang Su; Yongfeng Chen
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

3.  Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.

Authors:  Michael Kasperkiewicz; Rebecca Strong; Marc Yale; Patrick Dunn; David T Woodley
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-14       Impact factor: 9.228
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.